- 3258.284
- +18.728+0.58%
What Do Weight-loss Drugs Mean for the Diet Industry?
Investors in Johnson & Johnson (NYSE:JNJ) Have Unfortunately Lost 8.0% Over the Last Year
It's easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do both better or worse than that. Unfortunately the Johnson & Johnson (NYSE:JNJ) shar
With 53% Ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) Boasts of Strong Institutional Backing
#礼来 2024Q1 Performance Topic #持续更新
Financial report preview
#辉瑞 2024Q1 Performance Topic #持续更新
Financial report preview
Amgen's Blincyto Data Send Cullinan Higher
WHO Picks JN.1 Variant for Next Set of COVID Vaccines
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Eliminates hundreds of treatments! Pfizer (PFE.US) gene therapy approved for listing by FDA
Pfizer/PFE.us (Pfizer/PFE.us) announced that the US FDA has approved the single-use gene therapy Beqvez (fidanacogene elaparvovec) it has developed to treat adults with moderate to severe hemophilia B aged 18 or above.
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
Jim Cramer, the host of CNBC's "Mad Money," has outlined the key events that investors should keep an eye on in the upcoming week.What Happened: Cramer highlighted the significant events scheduled for
Preview -- Barron's
Tuesday 4/30 It's the busiest week of first-quarter earnings season, as more than 150 S&P 500 index companies are scheduled to publish their results. Advanced Micro Devices, Amazon.com, Eli Lilly, an
Moderna(MRNA.US) Director Sells US$1.62 Million in Common Stock
$Moderna(MRNA.US)$ Director AFEYAN NOUBAR sold 15,000 shares of common stock on Apr 24, 2024 at an average price of $108.3224 for a total value of $1.62 million.Source: Announcement What is statement
Gilead Sciences To Go Ex-Dividend On June 14th, 2024 With 0.77 USD Dividend Per Share
April 27th - $Gilead Sciences(GILD.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 14th, 2024 will receive 0.77 USD dividend per share on June 27th, 2024. The ex-div
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Vaccinex Files to Sell 193,000 Shares of Common Stock for Holders
Pfizer Options Spot-On: On April 26th, 118.91K Contracts Were Traded, With 3.21 Million Open Interest
On April 26th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 118.91K options for the day, of which put options accounted for 37.64% of the total transactions, and call
Inovio Pharmaceuticals Form 13G Shows Deep Track Capital, LP Reported A 9.99% Stake In The Co As Of April, 16, 2024
Inovio Pharmaceuticals Form 13G Shows Deep Track Capital, LP Reported A 9.99% Stake In The Co As Of April, 16, 2024
Sector Update: Health Care Stocks Edge Higher Late Afternoon
Health care stocks were advancing late Friday afternoon, with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) rose